The Drug Enforcement Administration proposes adjusting the fee schedule for registration and reregistration fees necessary to recover the costs of its Diversion Control Program relating to the registration and control of the manufacture, distribution, dispensing, importation and exportation of controlled substances and list I chemicals as mandated by the Controlled Substances Act.
US Federal Register - DEA Telehealth Rules · March 16, 2020
DEA Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants
Original title: Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants
DEA proposes adjusting fee schedule for controlled substance and List I chemical registrants to recover Diversion Control Program costs.
Published by US Federal Register - DEA Telehealth Rules. HealthSignal links to the original document; the summary above is extracted from the source text.